Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Stereotaxis, Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
STXS
NYSE American
3850
www.stereotaxis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Stereotaxis, Inc.
3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025
- Mar 26th, 2025 2:06 pm
Nvidia’s Support Boosts Stereotaxis (STXS) in Advancing Robotic Surgery
- Mar 23rd, 2025 9:39 pm
Stereotaxis Jumps 15% on NVIDIA's AI-Driven Collaboration: Is It a Buy Now?
- Mar 21st, 2025 4:02 pm
March 2025 Penny Stocks With Promising Prospects
- Mar 20th, 2025 5:05 pm
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
- Mar 19th, 2025 12:01 pm
Stereotaxis to Present at 37th Annual Roth Conference
- Mar 10th, 2025 12:02 pm
Stereotaxis Stock Slides Despite MAGiC Sweep Catheter FDA Submission
- Mar 7th, 2025 5:03 pm
STXS Stock Tumbles Despite EMAGIN Catheter Submission for Approval
- Mar 4th, 2025 5:15 pm
Stereotaxis sees double digit revenue growth for FY25
- Mar 4th, 2025 12:45 pm
Stereotaxis submits EMAGIN catheter for regulatory clearance
- Mar 4th, 2025 12:40 pm
Stereotaxis announces FDA regulatory submission for MAGiC Sweep catheter
- Mar 4th, 2025 12:36 pm
Stereotaxis Inc (STXS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...
- Mar 4th, 2025 7:01 am
Q4 2024 Stereotaxis Inc Earnings Call
- Mar 4th, 2025 5:34 am
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
- Mar 3rd, 2025 1:45 pm
Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery
- Mar 3rd, 2025 12:32 pm
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance
- Mar 3rd, 2025 12:31 pm
Stereotaxis Reports 2024 Full Year Financial Results
- Mar 3rd, 2025 12:30 pm
TransMedics (TMDX) Q4 Earnings and Revenues Beat Estimates
- Feb 27th, 2025 10:30 pm
Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference
- Feb 25th, 2025 1:03 pm
STXS Stock Gains Following the First Order for its GenesisX
- Feb 4th, 2025 1:18 pm
Scroll